Inhibition of tumor growth and angiogenesis of tamoxifen-resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor.

Name: Inhibition of tumor growth and angiogenesis of tamoxifen-resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor.
Author: Kim, Ji Won

Inhibition of tumor growth and angiogenesis of tamoxifen-resistant breast cancer cells by ruxolitinib, a selective JAK2 inhibitor. — المؤلف: Kim, Ji Won — Oncology letters Apr 2019

المؤلف: Kim, Ji Won
النشر: Oncology letters Apr 2019
الوصف: 3981-3989 p.